Progression of leprosy disability after discharge: is multidrug therapy enough? - Wikidata - awgldk - TriplyDB

Progression of leprosy disability after discharge: is multidrug therapy enough?

Progression of leprosy disability after discharge: is multidrug therapy enough?

http://www.wikidata.org/entity/Q34843268

about

Uniform multidrug therapy for leprosy patients in Brazil (U-MDT/CT-BR): Results of an open label, randomized and controlled clinical trial, among multibacillary patients.Minocycline in leprosy patients with recent onset clinical nerve function impairment.Grade 2 disabilities in leprosy patients from Brazil: Need for follow-up after completion of multidrug therapy

P2860

Q39348293-37964CD5-A560-4521-86CC-9BD91A7A0271 Q51842491-1DE665F5-1CCF-4551-9F93-948FD5085336 Q57952525-772EC019-D8DA-44D5-9628-208607408986

P2860

Progression of leprosy disability after discharge: is multidrug therapy enough?

http://www.wikidata.org/entity/Q34843268

description

2013 nî lūn-bûn

@nan

2013 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Progression of leprosy disability after discharge: is multidrug therapy enough?

@ast

Progression of leprosy disability after discharge: is multidrug therapy enough?

@en

Progression of leprosy disability after discharge: is multidrug therapy enough?

@nl

type

label

Progression of leprosy disability after discharge: is multidrug therapy enough?

@ast

Progression of leprosy disability after discharge: is multidrug therapy enough?

@en

Progression of leprosy disability after discharge: is multidrug therapy enough?

@nl

prefLabel

Progression of leprosy disability after discharge: is multidrug therapy enough?

@ast

Progression of leprosy disability after discharge: is multidrug therapy enough?

@en

Progression of leprosy disability after discharge: is multidrug therapy enough?

@nl

P1433

Q34843268-616EA6A0-FF0D-495D-B9AE-38A3DC025FBB

P1476

Q34843268-5667E4EB-3F19-46F1-AF1F-C5F1727E6565

P2093

Q34843268-04688182-45FA-4173-90F8-F68C7EB16673

Q34843268-32252161-C98C-4E15-8CD5-AAE119A63932

Q34843268-3CB159B2-EBA7-439B-9A30-E2D563F50330

Q34843268-92462203-13C4-49EB-81A9-F631A1DE5D36

Q34843268-A75EFAA3-BA6B-404D-B09A-CC6F9FC94D9B

Q34843268-F121E2DD-ACC7-4645-A18D-692C3E096D9B

Q34843268-F3C678C6-9A15-45E0-B191-C428C66A498A

P2860

Q34843268-0C4835AA-B2A2-48C2-B2EA-BD569BA89695

Q34843268-1CD541FA-776F-48F5-A865-CAC5C4AC67ED

Q34843268-302C5439-C96E-45CF-8396-7CD7CCF5632E

Q34843268-34A50BE4-D1EF-42DE-ACC0-E2D5069883F9

Q34843268-541A3BD1-866A-435A-AADD-3211DBF1CF17

Q34843268-6410B63A-3370-4966-910E-4728F6CD854E

Q34843268-670C341C-AB53-421C-99A0-CCC42378FB46

Q34843268-7FD6E5D5-3C19-4933-BD6F-7C8146E5D8E7

Q34843268-878FC110-182E-42B5-AA6F-A7BC78591BC8

Q34843268-8AB10558-2A49-4E94-BDFA-E61684DF2AA6

P304

Q34843268-2CA9289E-1523-44C6-AB99-F31DC9475481

P31

Q34843268-15F3D443-7B5B-4797-B7B0-C64D34356A68

P356

Q34843268-E34F7CD4-4BE2-4892-A3EC-9BD8765C4133

P433

Q34843268-195A07E1-C328-4727-88ED-EB74AEB763CD

P478

Q34843268-CB43A09A-2EC8-45CF-B524-C9456A49885F

P50

Q34843268-562DA1FE-ACD3-4765-8192-5B34AB483B61

P577

Q34843268-89AF7331-792D-4FAE-857F-14E3A32A8624

P5875

Q34843268-96F87707-25AD-4881-9A56-22FED59E0BDE

P698

Q34843268-8264C2E6-204D-4DF6-AAE3-4CBC61D9EE0A

P921

Q34843268-06739339-752B-4EBD-A508-1A15ED37EFBB

Q34843268-6B243218-5C6C-4FBD-BE8C-426882A7C0C9

P932

Q34843268-B9A6B778-57D0-41D6-80F1-4FD3646CB260

P356

P1433

Tropical Medicine and International Health

P1476

Progression of leprosy disability after discharge: is multidrug therapy enough?

@en

P2093

Anna Maria Sales

http://www.w3.org/2001/XMLSchema#string

Dayse Pereira Campos

http://www.w3.org/2001/XMLSchema#string

Emanuel Rangel

http://www.w3.org/2001/XMLSchema#string

José Augusto da Costa Nery

http://www.w3.org/2001/XMLSchema#string

Maria Lucia Fernandes Penna

http://www.w3.org/2001/XMLSchema#string

Mariana Andrea Hacker

http://www.w3.org/2001/XMLSchema#string

Nádia Cristina Düppre

http://www.w3.org/2001/XMLSchema#string

P2860

The continuing challenges of leprosy

Preventing nerve function impairment in leprosy: validation and updating of a prediction rule.

Predicting neuropathy and reactions in leprosy at diagnosis and before incident events-results from the INFIR cohort study.

Disability in people affected by leprosy: the role of impairment, activity, social participation, stigma and discrimination

Answering the rehabilitation needs of leprosy-affected persons in integrated setting through primary health care services and community-based rehabilitation.

Risk of developing disability in pre and post-multidrug therapy treatment among multibacillary leprosy: Agra MB Cohort study.

Spatial distribution of leprosy in the Amazon region of Brazil.

Disability index for leprosy patients.

The INFIR Cohort Study: investigating prediction, detection and pathogenesis of neuropathy and reactions in leprosy. Methods and baseline results of a cohort of multibacillary leprosy patients in north India.

Dynamics of impairment during and after treatment: the AMFES cohort.

P304

1145-1153

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/TMI.12156

http://www.w3.org/2001/XMLSchema#string

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

18

http://www.w3.org/2001/XMLSchema#string

P50

Euzenir Nunes Sarno

P577

2013-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

255788373

http://www.w3.org/2001/XMLSchema#string

P698

23937704

http://www.w3.org/2001/XMLSchema#string

P921

P932

4285222

http://www.w3.org/2001/XMLSchema#string